Abstract:Modic changes are radiographic features associated with microfracture, low-virulence organism infection and chronic inflammation with inflammatory cell infiltration in the vertebral endplate region. Mast cells, as innate immune cells similar to macrophages, are present in painful degenerated intervertebral discs. However, the involvement and mechanisms of mast cells in the development of Modic changes remain unclear. Herein, we found increased mast cell infiltration in samples from patients with Modic changes and in mouse models of Modic changes. To clarify the role of mast cells in the progression of Modic changes, we used mast cell-deficient (KITW-SH/W-SH) mice to construct a model of Modic changes and found that the severity of Modic changes in KITW-SH/W-SH mice was significantly lower than that in WT mice. These findings were further supported by the use of a mast cell-specific activator (compound 48/80) and a stabilizer (cromolyn). Furthermore, we found that mast cells were not activated via the classic IgE pathway in the Modic change models and that Mrgprb2 is the specific receptor for mast cell activation reported in recent studies. Then, we utilized Mrgprb2 knockout mice to demonstrate that Mrgprb2 knockout inhibited mast cell activation and thus reduced the degree of Modic changes. Transcriptomic sequencing revealed aberrant PI3K-AKT and MAPK pathway activation in the Mrgprb2-deficient mast cells. Additionally, Mrgpbrb2-activated mast cells regulate immune niches by recruiting macrophages, promoting M1 polarization and reducing M2 polarization, thereby promoting the progression of Modic changes. These findings suggest that mast cells may serve as a novel therapeutic target for addressing Modic changes. Degenerative disorders of the lower back are common and can greatly affect life quality. The research by Ji et al. examines the role of mast cells (a kind of immune cell) in the development of these disorders. They discovered that mast cells aid in the progression of Modic changes (a type of spinal degeneration), by affecting the metabolism of the endplates (the ends of the spinal bones) and altering the immune response. This was shown through experiments with human tissue samples, animal models, and cell studies. The results suggest that focusing on mast cells could be a potential treatment for Modic changes. The research also emphasizes the significance of the Mrgprb2 receptor (a protein that activates mast cells) as a potential drug target. "This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author."

Spatiotemporal Patterns of Substance P-Bound MRGPRX2 Reveal a Novel Connection Between Macropinosome Resolution and Secretory Granule Regeneration in Mast Cells

The Underlying Rab Network of MRGPRX2-Stimulated Secretion Unveils the Impact of Receptor Trafficking on Secretory Granule Biogenesis and Secretion

Neuronal substance P-driven MRGPRX2-dependent mast cell degranulation products differentially promote vascular permeability

Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.

MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of Gαi, Gαq, Ca++ Channels, ERK1/2 and PI3K—Interconnection between Early and Late Signaling

Action of substance P and PAMP(9-20) on different excitation sites of MRGPRX2 induces differences in mast cell activation

Mrgprb2-mediated Mast Cell Activation Exacerbates Modic Changes by Regulating Immune Niches

MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo‐allergic and anaphylactoid reactions

Mrgprb2-dependent mast cell activation plays a crucial role in acute colitis

Differential MRGPRX2-dependent activation of human mast cells by polymyxins and octapeptins

Roles of a Mast Cell-Specific Receptor MRGPRX2 in Host Defense and Inflammation

MrgprX2 regulates mast cell degranulation through PI3K/AKT and PLCγ signaling in pseudo-allergic reactions

Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist

Cytokine Stimulation by MRGPRX2 Occurs with Lower Potency than by FcεRI Aggregation but with Similar Dependence on the Extracellular Signal–Regulated Kinase 1/2 Module in Human Skin Mast Cells

Development of an Environmentally Sensitive Fluorescent Peptide Probe for MrgX2 and Application in Ligand Screening of Peptide Antibiotics.

MAS-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs

The Origin, Expression, Function and Future Research Focus of a G Protein-coupled Receptor, Mas-related Gene X2 (MrgX2)

Typical Antimicrobials Induce Mast Cell Degranulation and Anaphylactoid Reactions Via MRGPRX2 and Its Murine Homologue MRGPRB2

Exogenous Analogues of Substance P Trigger Pseudo-Allergic Reactions Through Activation of MRGPRX2

Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists

Polymyxin B and Polymyxin E Induce Anaphylactoid Response Through Mediation of Mas-related G Protein-Coupled Receptor X2.